Diabetes · 2020 · 49 citations · 39 references
MedicineCell BiologyOphthalmologyDiabetologyOcular DiseaseOcular PathologyAngiogenesisDiabetes MellitusDiabetic RetinopathyRetinal Vascular DiseaseBlood-retinal Barrier DisruptionBlood-retinal Barrier DysfunctionDiabetic Retinopathy ProgressionIn Vivo ImagingIn Vivo Retinal ImagingPericyte LossRetinal Microvascular ChangesVascular Pericytes
Diabetic retinopathy is a potentially blinding eye disease that threatens the vision of one-ninth of patients with diabetes. Progression of the disease has long been attributed to an initial dropout of pericytes that enwrap the retinal microvasculature. Revealed through retinal vascular digests, a subsequent increase in basement membrane bridges was also observed. Using cell-specific markers, we demonstrate that pericytes rather than endothelial cells colocalize with these bridges. We show that the density of bridges transiently increases with elevation of Ang-2, PDGF-BB, and blood glucose; is rapidly reversed on a timescale of days; and is often associated with a pericyte cell body located off vessel. Cell-specific knockout of KLF4 in pericytes fully replicates this phenotype. In vivo imaging of limbal vessels demonstrates pericyte migration off vessel, with rapid pericyte filopodial-like process formation between adjacent vessels. Accounting for off-vessel and on-vessel pericytes, we observed no pericyte loss relative to nondiabetic control retina. These findings reveal the possibility that pericyte perturbations in location and process formation may play a role in the development of pathological vascular remodeling in diabetic retinopathy.
39
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin, Ignacio Arganda‐Carreras, Erwin Frise et al. · Nature Methods · 2012 · 70.9K citations
David G. Cogan · Archives of Ophthalmology · 1961 · 810 citations
Medicine, Ophthalmology, Pathology +17
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Michael R. Mancuso, Rachel Davis, Scott M. Norberg et al. · Journal of Clinical Investigation · 2006 · 798 citations · Full text
Medicine, Oncology, Pharmacology +14